bioAffinity Technologies, Inc. (BIAF) — Dilution Risk Analysis

Current Snapshot

bioAffinity Technologies, Inc. (BIAF) has a DilutionWatch score of 81/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
8,101,725 Source
Public Float
4,385,272 Source
Float as % of Outstanding
54.1%

Dilution Risk Score

Score: 81/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: EFFECT 2, 8-K 3, XBRL 2.

FormFiledAccession
EFFECT 2026-09-04 9999999995-26-002900
8-K 2026-08-14 0001493152-26-038437
xbrl 2026-06-30 xbrl-7188-xbrl_warrant
8-K 2026-06-18 0001493152-26-029384
EFFECT 2026-06-16 9999999995-26-002028
8-K 2026-04-30 0001493152-26-020591
xbrl 2022-12-31 xbrl-7188-xbrl_convertible

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 3 months Source
Three-year share count growth 326.31% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 81/10) Source
Cash Runway
3 months Source
Share Count Growth (3-Year)
326.31% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.